Myristyl Nicotinate Handling & Solubility Protocol

Myristyl nicotinate is a lipophilic ester of nicotinic acid (vitamin B3) and myristyl alcohol that requires careful solvent selection, controlled-temperature storage, and precise reconstitution to ensure reproducible results in biological and cosmetic research assays.

Product SKU

M646658

Chemical Class

Nicotinic acid ester (Vitamin B3 fatty alcohol ester)

Lipophilicity

High; myristyl (C14) chain confers strong lipophilicity, limiting aqueous solubility

Recommended Storage

Store at –20 °C, sealed, away from light and moisture; review CoA for lot-specific guidance

Preferred Solvents

DMSO, ethanol, or warm vegetable oils; water solubility is very low — aqueous vehicles require a surfactant or co-solvent

Reference Compound (MCE)

HY-133027

Materials & Safety Precautions

Before beginning, gather the following materials: Myristyl nicotinate (Aladdin SKU M646658), analytical balance, amber glass vials, anhydrous DMSO or ethanol (≥99.5% purity), nitrogen or argon gas source for blanketing, micropipettes, and appropriate personal protective equipment (lab coat, nitrile gloves, and safety glasses).

Although Myristyl nicotinate is not classified as acutely hazardous at research-scale quantities, standard laboratory safety practices apply. Avoid inhalation of powder or aerosols. Work in a well-ventilated area or fume hood when preparing concentrated stock solutions. Consult the Safety Data Sheet (SDS) specific to lot M646658 for comprehensive hazard information before use.

Stock Solution Preparation

Step 1 — Equilibrate the vial. Remove the sealed vial of Myristyl nicotinate from –20 °C storage and allow it to equilibrate to room temperature (approximately 15–20 minutes) before opening. This prevents condensation from introducing moisture into the compound.

Step 2 — Weigh accurately. Using a calibrated analytical balance, weigh the required mass of compound into a tared amber glass vial. Record the exact mass to four decimal places.

Step 3 — Add solvent. For a DMSO stock solution, add anhydrous DMSO to achieve the desired concentration (commonly 10–50 mM). Because of the high lipophilicity of the C14 myristyl chain, gentle warming to 37 °C in a water bath with vortexing may be necessary to achieve complete dissolution. For ethanol-based stocks, the same warming approach applies. Note: confirm complete visual clarity before proceeding; particulate matter indicates incomplete dissolution.

Step 4 — Aliquot and blanket. Once fully dissolved, aliquot the stock solution into single-use volumes to avoid repeated freeze–thaw cycles. Blanket each vial with inert gas (N₂ or Ar) before sealing with Parafilm to minimise oxidation. Label vials with compound name, SKU, concentration, solvent, date, and operator initials.

Step 5 — Store aliquots. Store DMSO or ethanol aliquots at –20 °C for short-term use (up to 3 months). For longer-term storage, –80 °C is advisable. Avoid storing aqueous dilutions due to precipitation risk.

Working Solution Preparation & Assay Dilution

Aqueous dilution guidance. Myristyl nicotinate has very low water solubility due to its long alkyl chain. When aqueous working solutions are required (e.g., for cell-based assays), dilute the DMSO stock into pre-warmed culture medium (37 °C) while vortexing vigorously. Keep the final DMSO concentration ≤0.1% (v/v) to minimise cytotoxic effects, unless your assay system has been validated for higher concentrations. If precipitation occurs, consider using a carrier such as hydroxypropyl-β-cyclodextrin (HPβCD) or a Cremophor EL / Tween-80 vehicle.

Lipid-based formulations. For topical or in vitro skin-model studies, Myristyl nicotinate may be incorporated directly into lipid vehicles (e.g., isopropyl myristate, squalane, or mineral oil) at the desired percentage (w/w). Heat the oil phase to 50–60 °C, add the compound, mix until homogeneous, then cool to room temperature before use.

Concentration verification. When high accuracy is required, verify the working solution concentration by UV-Vis spectrophotometry using the known absorbance characteristics of the pyridine ring of nicotinate (λmax approximately 262 nm in ethanol). Prepare a calibration curve using serial dilutions of the stock solution.

Troubleshooting

Problem: Compound does not dissolve fully in DMSO at room temperature.
Solution: Warm the sealed vial in a 37–50 °C water bath for 5–10 minutes with periodic vortexing. If undissolved material persists, sonicate briefly (≤30 seconds, pulse mode) in an ultrasonic bath. Ensure DMSO is anhydrous; water contamination significantly reduces solubility of lipophilic esters.

Problem: Precipitation upon dilution into aqueous medium.
Solution: Pre-warm the aqueous medium to 37 °C and add the compound stock dropwise while vortexing. Reduce the target concentration or increase the proportion of co-solvent. Alternatively, pre-form a cyclodextrin inclusion complex before aqueous dilution.

Problem: Suspected hydrolysis of the ester bond.
Solution: Ester bonds are susceptible to hydrolysis under strongly acidic or basic conditions and at elevated temperatures. Prepare fresh working solutions for each experiment. Avoid prolonged exposure to pH extremes. Store stock solutions under inert gas at –20 °C or below. Confirm compound integrity by TLC or HPLC if results are inconsistent.

Problem: Inconsistent biological results between experiments.
Solution: Standardise the stock solution preparation procedure (same solvent lot, same temperature, same mixing time). Verify concentration of each working solution by UV spectrophotometry. Use single-use aliquots to eliminate freeze–thaw variability.

Frequently asked questions

What is the recommended solvent for preparing a Myristyl nicotinate stock solution?

Anhydrous DMSO or ethanol (≥99.5% purity) are the preferred solvents for preparing stock solutions of Myristyl nicotinate. Gentle warming to 37 °C may be required to achieve complete dissolution due to the compound's high lipophilicity. Aqueous solubility is very limited and co-solvents or surfactants are required for aqueous formulations.

How should Myristyl nicotinate (M646658) be stored to maintain stability?

Myristyl nicotinate should be stored at –20 °C in a sealed, light-protected container away from moisture. Stock solutions in DMSO or ethanol should be aliquoted, blanketed with inert gas, and stored at –20 °C for up to approximately 3 months, or at –80 °C for longer periods. Repeated freeze–thaw cycles should be avoided.

Can Myristyl nicotinate be directly dissolved in cell culture medium?

Direct dissolution in aqueous cell culture medium is not recommended because of the compound's very low water solubility. Instead, prepare a concentrated stock in DMSO and dilute into pre-warmed medium (37 °C) while vortexing, keeping the final DMSO concentration at ≤0.1% (v/v). If precipitation occurs, use a solubilising agent such as hydroxypropyl-β-cyclodextrin.

How can I verify that the working solution concentration is accurate?

The nicotinate (pyridine ring) chromophore absorbs UV light at approximately 262 nm in ethanol. Prepare a calibration curve from serial dilutions of your stock solution and measure absorbance by UV-Vis spectrophotometry to calculate the actual concentration of working solutions. For critical experiments, HPLC purity analysis is also advisable.

Is Myristyl nicotinate the same as niacin or niacinamide?

No. Myristyl nicotinate is an ester formed by conjugating nicotinic acid (niacin) with myristyl alcohol (1-tetradecanol), making it structurally distinct from both niacin and niacinamide (nicotinamide). The esterification significantly increases lipophilicity compared to free niacin, which affects formulation strategy, membrane permeability, and biological activity profile.

References

1. Aladdin Scientific product page: Myristyl nicotinate, SKU M646658. Aladdin Scientific.
2. MedChemExpress (MCE) compound entry HY-133027: Myristyl nicotinate. MedChemExpress LLC.
3. Sigma-Aldrich Solvent Miscibility and Compatibility Guide. Merck KGaA. (General reference for solvent selection of lipophilic compounds.)
4. Bronaugh RL, Maibach HI, eds. Percutaneous Absorption: Drugs, Cosmetics, Mechanisms, Methods. 4th ed. CRC Press; 2005. (General reference for topical nicotinate ester formulations.)

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.